139 related articles for article (PubMed ID: 35189405)
1. Nitric oxide in multikinase inhibitor-induced hand-foot skin reaction.
Chen L; Wu Z; Yang L; Chen Y; Wang W; Cheng L; Li C; Lv D; Xia L; Chen J; Tang L; Zhang LI; Zhang S; Luo J
Transl Res; 2022 Jul; 245():82-98. PubMed ID: 35189405
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF) antibody significantly increases the risk of hand-foot skin reaction to multikinase inhibitors (MKIs): A systematic literature review and meta-analysis.
Zhu Y; Zhang X; Lou X; Chen M; Luo P; He Q
Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):659-667. PubMed ID: 29543385
[TBL] [Abstract][Full Text] [Related]
3. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs).
Anderson R; Jatoi A; Robert C; Wood LS; Keating KN; Lacouture ME
Oncologist; 2009 Mar; 14(3):291-302. PubMed ID: 19276294
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of hand-foot skin reaction caused by tyrosine kinase inhibitors based on direct keratinocyte toxicity and vascular endothelial growth factor receptor-2 inhibition.
Hasan Alshammari A; Masuo Y; Fujita KI; Shimada K; Iida N; Wakayama T; Kato Y
Biochem Pharmacol; 2022 Mar; 197():114914. PubMed ID: 35041812
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a protocol including heparin ointment for treatment of multikinase inhibitor-induced hand-foot skin reactions.
Li JR; Yang CR; Cheng CL; Ho HC; Chiu KY; Su CK; Chen WM; Wang SS; Chen CS; Yang CK; Ou YC
Support Care Cancer; 2013 Mar; 21(3):907-11. PubMed ID: 23262811
[TBL] [Abstract][Full Text] [Related]
6. Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death.
Zimmerman EI; Gibson AA; Hu S; Vasilyeva A; Orwick SJ; Du G; Mascara GP; Ong SS; Chen T; Vogel P; Inaba H; Maitland ML; Sparreboom A; Baker SD
Cancer Res; 2016 Jan; 76(1):117-26. PubMed ID: 26677977
[TBL] [Abstract][Full Text] [Related]
7. Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib.
Ochi M; Kamoshida T; Ohkawara A; Ohkawara H; Kakinoki N; Hirai S; Yanaka A
World J Gastroenterol; 2018 Jul; 24(28):3155-3162. PubMed ID: 30065561
[TBL] [Abstract][Full Text] [Related]
8. Multikinase Inhibitor-Induced Hand-Foot Skin Reaction: A Review of Clinical Presentation, Pathogenesis, and Management.
Chanprapaph K; Rutnin S; Vachiramon V
Am J Clin Dermatol; 2016 Aug; 17(4):387-402. PubMed ID: 27221667
[TBL] [Abstract][Full Text] [Related]
9. Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management.
McLellan B; Ciardiello F; Lacouture ME; Segaert S; Van Cutsem E
Ann Oncol; 2015 Oct; 26(10):2017-26. PubMed ID: 26034039
[TBL] [Abstract][Full Text] [Related]
10. Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.
Azad NS; Aragon-Ching JB; Dahut WL; Gutierrez M; Figg WD; Jain L; Steinberg SM; Turner ML; Kohn EC; Kong HH
Clin Cancer Res; 2009 Feb; 15(4):1411-6. PubMed ID: 19228742
[TBL] [Abstract][Full Text] [Related]
11. The risk of hand-foot skin reaction to axitinib, a novel VEGF inhibitor: a systematic review of literature and meta-analysis.
Fischer A; Wu S; Ho AL; Lacouture ME
Invest New Drugs; 2013 Jun; 31(3):787-97. PubMed ID: 23345001
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, treatment outcomes, and prognosis in patients with MKIs-associated hand-foot skin reaction: a retrospective study.
Shou L; Chen J; Shao T; Zhang Y; Zhao S; Chen S; Shu Q
Support Care Cancer; 2023 Jun; 31(7):375. PubMed ID: 37273007
[TBL] [Abstract][Full Text] [Related]
13. Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Lacouture ME; Wu S; Robert C; Atkins MB; Kong HH; Guitart J; Garbe C; Hauschild A; Puzanov I; Alexandrescu DT; Anderson RT; Wood L; Dutcher JP
Oncologist; 2008 Sep; 13(9):1001-11. PubMed ID: 18779536
[TBL] [Abstract][Full Text] [Related]
14. Zinc supplementation is associated with improvement in hand-foot skin reaction in patients on vascular endothelial growth factor receptor-tyrosine kinase inhibitors: A cohort study.
Lu CW; Yeh CN; Hsu HC; Chen CB; Yang TS; Pan YR; Chung WH; Hung SI
J Am Acad Dermatol; 2024 Apr; 90(4):814-815. PubMed ID: 38065319
[No Abstract] [Full Text] [Related]
15. Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer.
Kobayashi K; Kawakami K; Yokokawa T; Aoyama T; Suzuki K; Wakatsuki T; Suenaga M; Sato H; Sugiyama E; Yamaguchi K; Hama T
Oncology; 2019; 96(4):200-206. PubMed ID: 30763946
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management.
Ai L; Xu Z; Yang B; He Q; Luo P
Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1121-1127. PubMed ID: 31679411
[No Abstract] [Full Text] [Related]
17. s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide.
Luo P; Yan H; Chen X; Zhang Y; Zhao Z; Cao J; Zhu Y; Du J; Xu Z; Zhang X; Zeng S; Yang B; Ma S; He Q
Cell Res; 2020 Sep; 30(9):779-793. PubMed ID: 32296111
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy and Safety of the Shouzu Ning Decoction Treatment for Multi-Kinase Inhibitors-Associated Severe Hand-Foot Skin Reaction.
Shou L; Shao T; Zhao F; Chen S; Chen Q; Shu Q
Cancer Manag Res; 2021; 13():45-53. PubMed ID: 33442293
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literature.
Massey PR; Okman JS; Wilkerson J; Cowen EW
Support Care Cancer; 2015 Jun; 23(6):1827-35. PubMed ID: 25471178
[TBL] [Abstract][Full Text] [Related]
20. Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis.
Belum VR; Wu S; Lacouture ME
Invest New Drugs; 2013 Aug; 31(4):1078-86. PubMed ID: 23700287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
